Shares in Eli Lilly rise as Zepbound weight-loss study shows solid success
Lilly said patients taking Zepbound lost about 20% of their weight on average compared with nearly 14% for Wegovy. The drug maker also said more patients taking Zepbound achieved at least 25% weight loss.